CD4 and neoplasm: The decreased number of Treg cells and MDSCs in spleen of TSA-treated mice, compared to the vehicle-treated group could be because of the decreased number of total splenic CD4+ T cells associated with reduced tumor size (Supplementary Figure 1), rather than the direct inhibitory effects of TSA on Treg cells and MDSCs.